Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Transfusion; Transfusion dependency; Iron overload; Chelation therapy; Cardiac death
مقالات ISI سندرم های میلوسپلاستی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سندرم های میلوسپلاستی; Age; Comorbidities; MDS; Myelodysplastic syndromes; Prognosis; Sex; Survival; Assessment
Keywords: سندرم های میلوسپلاستی; Auto-immunité; Cancer; Lymphomes; Vascularites; Syndromes myélodysplasiques; Autoimmunity; Cancer; Lymphoma; Vasculitis; Myelodysplastic syndromes;
Keywords: سندرم های میلوسپلاستی; Humans; Myelodysplastic syndromes; Prognosis; Retrospective studies; Risk assessment; Risk factors; Survival analysis;
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Population-based; Incidence; Treatment; Survival; Epidemiology; Registry
Keywords: سندرم های میلوسپلاستی; Acute myeloid leukemia; Allogeneic transplantation; Myelodysplastic syndromes; Performance status; Prognosis; Therapy;
Keywords: سندرم های میلوسپلاستی; Dendritic cells; Myelodysplastic syndromes; Flow-cytometry; Bone marrow; International Prognostic Scoring System (IPSS);
Keywords: سندرم های میلوسپلاستی; DNA methylation; Targeted bisulfite sequencing; Next-generation sequencing; ACBS-seq; array capture bisulfite sequencing; AML; acute myeloid leukemia; BSPP; bisulfite padlock probes; CGI; CpG island; COBRA; combined bisulfite and restriction analysis; DMH
Keywords: سندرم های میلوسپلاستی; 5-hmC; 5-hydroxymethylcytosine; 5-mC; 5-methylcytosine; ADAM23; ADAM metallopeptidase domain 23; ADAMTS9; ADAM metallopeptidase with thrombospondin type 1 motif, 9; ARID1A; AT rich interactive domain 1A (SWI-like); AML; Acute myelocytic leukemia; ATBF1; A
Keywords: سندرم های میلوسپلاستی; Forensic radiology; Postmortem computed tomography; Autopsy; Myelodysplastic syndromes; Splenomegaly
Keywords: سندرم های میلوسپلاستی; Azacitidine; Myelodysplastic syndromes; Auto immune disorders
Keywords: سندرم های میلوسپلاستی; Blood transfusion; FACT-An; Anemia; Fatigue; Myelodysplastic syndromes
Study of DNA methyl transferase 3A mutation in acute myeloid leukemic patients
Keywords: سندرم های میلوسپلاستی; ASB-PCR; allele- specific blocker PCR; DNMT3A; DNA methyltransferase; BM; bone marrow; WBC; white blood cells; HGB; hemoglobin; CR; complete remission; ID; Induction death; OS; Overall survival; DFS; disease free survival; MPN; myeloproliferative neoplasm
Management of older adults with myelodysplastic syndromes (MDS)
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Older adults; Frailty; Comorbidity; Allogeneic hematopoietic stem cell transplant;
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Metaphases; Karyotype; Cytogenetics; Lower-risk; Overall survival; Progression-free survival;
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Lenalidomide; Del(5q) aberration; Erythropoietin; Prednisone;
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Ethnicity; Clinical features; Survival; Karyotype;
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Flow cytometry; Ogata score; CD33; CD34; Side scatter;
CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia
Keywords: سندرم های میلوسپلاستی; ANC; Absolute neutrophil count; AML; Acute myeloid leukemia; BL; Baseline; BM; Bone marrow; CI; Confidence intervals; CMML; Chronic myelomonocytic leukemia; CR; Complete remission; ECOG; Eastern Cooperative Oncology Group; HI; Hematologic improvement; HI-
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Apoptosis; Clinical trial; CD 95; Fas ligand; Erythropoiesis;
A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia
Keywords: سندرم های میلوسپلاستی; patient reported outcomes; quality of life; acute myeloid leukemia; myelodysplastic syndromes; clinical trials; phase 2/3;
Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Hematopoietic stem cell; Interleukin-2 receptor alpha subunit; Leukemia stem cell;
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; MDS; Iron overload; Iron chelation therapy; Clinical outcomes;
Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; NF-kB; Toll-like receptors; TNF-α; IL-8;
An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation
Keywords: سندرم های میلوسپلاستی; Acn; aconitase; AMPK; AMP-activated protein kinase; ANT; adenine nucleotide transporter; BMDDC; bone-marrow derived dendritic cells; ERα; estrogen receptor α; CSF; cerebrospinal fluid; ER; endoplasmic reticulum; ETS; electron transport system; GRP78/BiP
Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Chromosomal rearrangements; Molecular mutations; CHIP as seeds of leukemia; Classification and risk-stratification;
To chelate or not to chelate in MDS: That is the question!
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Transfusion; Iron chelation; Deferasirox; Deferoxamine; Deferiprone;
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Juvenile myelomonocytic leukemia; Hypomethylating agents; Hematopoietic stem cell transplantation; Epigenetic therapy;
MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Cancer epidemiology; Diagnosis; Prognosis; Classification; Treatment; Population; Registry;
Research paperRefractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Keywords: سندرم های میلوسپلاستی; AF; allele frequency; ANC; absolute neutrophil count; CCUS; clonal cytopenias of unknown significance; Hgb; hemoglobin; MCV; mean cell volume; MDS; myelodysplastic syndromes; RDW; red blood cell distribution width; WBC; white blood cell count; RNA splicin
Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016
Keywords: سندرم های میلوسپلاستی; BMFS; bone marrow failure syndromes; HSC; hematopoietic stem cell; BM; bone marrow; AML; acute myelogenous leukemia; MDS; myelodysplastic syndromes; LSC; leukemia stem cell; CHIP; clonal hematopoiesis of indeterminate potential; MDSCs; myeloid derived sup
Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Tet methylcytosine dioxygenase 2; Muation; Prognostic; Meta-analysis;
Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Acute myeloid leukemias; Genetic instability; DNA double-strand breaks; DNA damage response;
New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Classification; Prognosis; Subtypes;
Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome
Keywords: سندرم های میلوسپلاستی; EZH2; H3K27 methyltransferase; Myelodysplastic syndromes;
HaematologyPrognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; Bone marrow biopsy; myelodysplastic syndromes; Revised-International Prognostic Scoring System; prognosis; overall survival; leukaemia-free survival;
Individual risk assessment in MDS in the era of genomic medicine
Keywords: سندرم های میلوسپلاستی; Risk assessment; Myelodysplastic syndromes; Genomic analysis; IPSS-R;
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Population based cancer registries; Incidence; Classification; Mortality; Survival;
SEMA3A partially reverses VEGF effects through binding to neuropilin-1
Keywords: سندرم های میلوسپلاستی; AML; Acute myeloid leukemia; AML-MRC; Acute myeloid leukemia with myelodysplasia-related changes; BM; Bone marrow; BMSCs; Bone marrow stromal cells; HSCs; Hematopoietic stem cells; MVD; Microvascular density; MDS; Myelodysplastic syndromes; NRP1; Neuropil
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: سندرم های میلوسپلاستی; DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
Therapeutic targeting of RNA splicing in myelodysplasia
Keywords: سندرم های میلوسپلاستی; Myelodysplastic Syndromes; SF3B1; Splicing; SRSF2; U2AF1;
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Non-del(5q); Anemia; Red blood cell transfusion dependence; Treatment;
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Inflammasome polymorphisms; Susceptibility;
The disappearance of acute erythroid leukemia: An act of legerdemain at the World Health Organization
Keywords: سندرم های میلوسپلاستی; Classification; Erythroid leukemia; Myelodysplastic syndromes; Myelogenous leukemia;
Good riddance to the term “refractory anemia” in myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; WHO classification; Myelodysplastic syndromes; Cornelius Packard Rhodes; Refractory anemia; Disease classification; Puerto Rico; Racism; Medical ethics;
Splicing factor SF3B1 mutations and ring sideroblasts in myelodysplastic syndromes: a Brazilian cohort screening study
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; Ring sideroblasts; SF3B1;
Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; Copy number neutral loss of heterozygosity; Acquired uniparental disomy; Myelodysplastic syndromes; Complex chromosomal aberration; Mutation; TP53 gene
Why the stagnation in effective therapy for MDS?
Keywords: سندرم های میلوسپلاستی; MDS; Myelodysplastic syndromes; Therapy; Transplant; Trial design;
Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes
Keywords: سندرم های میلوسپلاستی; Biosimilar; Granulocyte colony-stimulating factor (G-CSF); Allogeneic hematopoietic stem transplantation; Normal donors; Siblings; Myelodysplastic syndromes; Acute myelogenous leukemia;
Down-regulation of EZH2 expression in myelodysplastic syndromes
Keywords: سندرم های میلوسپلاستی; Myelodysplastic syndromes; EZH2; Histone methylation; Epigenetics;